Skip to main content
FDA issues proposed rule on de novo classification

The FDA has released the De Novo Classification Proposed Rule to clarify and streamline its de novo pathway by outlining processes and criteria for reviewing novel low- to moderate-risk devices. The rule, which is open to public comment, is expected to encourage greater use of the pathway.

Full Story: